Antidepressant-like effects of Cortex Mori Radicis extract via bidirectional phosphorylation of glucocorticoid receptors in the hippocampus

Behavioural Brain Research

Volumn 236, Issue 1, 2013, Pages 56-61

  Lee, Mi Sook ^a   Park, Wan Soon ^a   Kim, Young Han ^a   Kwon, Seung Hae ^a   Jang, Yu Jung ^b   Han, Daeseok ^b   Morita, Kyoji ^c   Her, Song ^a  

^a Korea Basic Science Institute (KBSI)   (South Korea)

^b Korea Food Research Institute   (South Korea)

^c SHIKOKU UNIVERSITY   (Japan)

Author keywords

C fos immunoreactivity; Cortex Mori Radicis; Forced swim test; Glucocorticoid receptor; Limbic hypothalamic pituitary adrenocortical axis; Serine threonine protein phosphatase

Indexed keywords

CORTICOSTERONE; GLUCOCORTICOID RECEPTOR; MIFEPRISTONE; MULBERRY EXTRACT; PHOSPHATASE; PHOSPHATASE 5; PROTEIN C FOS; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDEPRESSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DENTATE GYRUS; DEPRESSION; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; DRUG RESEARCH; FORCED SWIMMING TEST; HIPPOCAMPUS; HORMONE RESPONSE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMOBILIZATION; IMMUNOREACTIVITY; MALE; MORNING DOSAGE; NONHUMAN; PLANT ROOT; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; ANTIDEPRESSIVE AGENTS; BLOTTING, WESTERN; CORTICOSTERONE; HINDLIMB SUSPENSION; HIPPOCAMPUS; HORMONE ANTAGONISTS; IMMUNOHISTOCHEMISTRY; MALE; MIFEPRISTONE; MORUS; MOTOR ACTIVITY; NUCLEAR PROTEINS; PHOSPHOPROTEIN PHOSPHATASES; PHOSPHORYLATION; PLANT BARK; PLANT EXTRACTS; PLANT ROOTS; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, WISTAR; RECEPTORS, GLUCOCORTICOID; SWIMMING;

EID: 84865959936     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2012.08.028     Document Type: Article

References (38)

1. Twardowska K., Rybakowski J. Limbic-hypothalamic-pituitary-adrenal axis in depression: literature review. Psychiatria Polska 1996, 30:741-755.
2. Cubala W.J., Landowski J. Serotoninergic system and limbic-hypothalamic-pituitary-adrenal axis (LHPA axis) in depression. Psychiatria Polska 2006, 40:415-430.
3. De Kloet E.R., Reul J.M. Feedback action and tonic influence of corticosteroids on brain function: a concept arising from the heterogeneity of brain receptor systems. Psychoneuroendocrinology 1987, 12:83-105.
4. Webster M.J., Knable M.B., O'Grady J., Orthmann J., Weickert C.S. Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders. Molecular Psychiatry 2002, 7:985-994. 924.
5. Bodwell J.E., Webster J.C., Jewell C.M., Cidlowski J.A., Hu J.M., Munck A. Glucocorticoid receptor phosphorylation: overview, function and cell cycle-dependence. The Journal of Steroid Biochemistry and Molecular Biology 1998, 65:91-99.
6. Wang Z., Frederick J., Garabedian M.J. Deciphering the phosphorylation code of the glucocorticoid receptor in vivo. Journal of Biological Chemistry 2002, 277:26573-26580.
7. Rogatsky I., Logan S.K., Garabedian M.J. Antagonism of glucocorticoid receptor transcriptional activation by the c-Jun N-terminal kinase. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:2050-2055.
8. Ismaili N., Garabedian M.J. Modulation of glucocorticoid receptor function via phosphorylation. Annals of the New York Academy of Sciences 2004, 1024:86-101.
9. Krstic M.D., Rogatsky I., Yamamoto K.R., Garabedian M.J. Mitogen-activated and cyclin-dependent protein kinases selectively and differentially modulate transcriptional enhancement by the glucocorticoid receptor. Molecular and Cellular Biology 1997, 17:3947-3954.
10. Chen W., Dang T., Blind R.D., Wang Z., Cavasotto C.N., Hittelman A.B., et al. Glucocorticoid receptor phosphorylation differentially affects target gene expression. Molecular Endocrinology 2008, 22:1754-1766.
11. Budziszewska B., Szymanska M., Leskiewicz M., Basta-Kaim A., Jaworska-Feil L., Kubera M., et al. The decrease in JNK- and p38-MAP kinase activity is accompanied by the enhancement of PP2A phosphate level in the brain of prenatally stressed rats. Journal of Physiology and Pharmacology 2010, 61:207-215.
12. Silverstein A.M., Galigniana M.D., Chen M.S., Owens-Grillo J.K., Chinkers M., Pratt W.B. Protein phosphatase 5 is a major component of glucocorticoid receptor. hsp90 complexes with properties of an FK506-binding immunophilin. Journal of Biological Chemistry 1997, 272:16224-16230.
13. Singab A.N., El-Beshbishy H.A., Yonekawa M., Nomura T., Fukai T. Hypoglycemic effect of Egyptian Morus alba root bark extract: effect on diabetes and lipid peroxidation of streptozotocin-induced diabetic rats. Journal of Ethnopharmacology 2005, 100:333-338.
14. Volpato G.T., Calderon I.M., Sinzato S., Campos K.E., Rudge M.V., Damasceno D.C. Effect of Morus nigra aqueous extract treatment on the maternal-fetal outcome, oxidative stress status and lipid profile of streptozotocin-induced diabetic rats. Journal of Ethnopharmacology 2011, 138:691-696.
15. Kim S.Y., Gao J.J., Kang H.K. Two flavonoids from the leaves of Morus alba induce differentiation of the human promyelocytic leukemia (HL-60) cell line. Biological and Pharmaceutical Bulletin 2000, 23:451-455.
16. Kim H.M., Han S.B., Lee K.H., Lee C.W., Kim C.Y., Lee E.J., et al. Immunomodulating activity of a polysaccharide isolated from Mori Cortex Radicis. Archives of Pharmacal Research 2000, 23:240-242.
17. Nade V.S., Kawale L.A., Naik R.A., Yadav A.V. Adaptogenic effect of Morus alba on chronic footshock-induced stress in rats. Indian Journal of Pharmacology 2009, 41:246-251.
18. Nade V.S., Yadav A.V. Anti-stress effect of ethyl acetate soluble fraction of Morus alba in chronic restraint stress. Pharmaceutical Biology 2010, 48:1038-1046.
19. Sattayasai J., Tiamkao S., Puapairoj P. Biphasic effects of Morus alba leaves green tea extract on mice in chronic forced swimming model. Phytotherapy Research 2008, 22:487-492.
20. Aisa B., Tordera R., Lasheras B., Del Rio J., Ramirez M.J. Cognitive impairment associated to HPA axis hyperactivity after maternal separation in rats. Psychoneuroendocrinology 2007, 32:256-266.
21. Porsolt R.D., Anton G., Blavet N., Jalfre M. Behavioural despair in rats: a new model sensitive to antidepressant treatments. European Journal of Pharmacology 1978, 47:379-391.
22. Steru L., Chermat R., Thierry B., Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 1985, 85:367-370.
23. Rittenhouse P.A., Lopez-Rubalcava C., Stanwood G.D., Lucki I. Amplified behavioral and endocrine responses to forced swim stress in the Wistar-Kyoto rat. Psychoneuroendocrinology 2002, 27:303-318.
24. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 2005, Elsevier, San Diego. 5th ed.
25. Lee M.S., Kwon E.H., Choi H.S., Kwon S.H., Lee C.H., Shim I.S., et al. Quantification of cellular uptake and in vivo tracking of transduction using real-time monitoring. Biochemical and Biophysical Research Communications 2010, 394:348-353.
26. Cryan J.F., Markou A., Lucki I. Assessing antidepressant activity in rodents: recent developments and future needs. Trends in Pharmacological Sciences 2002, 23:238-245.
27. Bai F., Li X., Clay M., Lindstrom T., Skolnick P. Intra- and interstrain differences in models of behavioral despair. Pharmacology Biochemistry and Behavior 2001, 70:187-192.
28. Porsolt R., Lenegre A. Behavioral models of depression. Experimental approaches to anxiety and depression 1992, 73-85. Wiley, London. J. Elliott, D. Heal, C. Marsden (Eds.).
29. De Kloet E.R., Vreugdenhil E., Oitzl M.S., Joels M. Brain corticosteroid receptor balance in health and disease. Endocrine Reviews 1998, 19:269-301.
30. Seckl J.R., Fink G. Antidepressants increase glucocorticoid and mineralocorticoid receptor mRNA expression in rat hippocampus in vivo. Neuroendocrinology 1992, 55:621-626.
31. Yau J.L., Olsson T., Morris R.G., Meaney M.J., Seckl J.R. Glucocorticoids, hippocampal corticosteroid receptor gene expression and antidepressant treatment: relationship with spatial learning in young and aged rats. Neuroscience 1995, 66:571-581.
32. Anacker C., Zunszain P.A., Cattaneo A., Carvalho L.A., Garabedian M.J., Thuret S., et al. Antidepressants increase human hippocampal neurogenesis by activating the glucocorticoid receptor. Molecular Psychiatry 2011, 16:738-750.
33. Adzic M., Djordjevic J., Djordjevic A., Niciforovic A., Demonacos C., Radojcic M., et al. Acute or chronic stress induce cell compartment-specific phosphorylation of glucocorticoid receptor and alter its transcriptional activity in Wistar rat brain. Journal of Endocrinology 2009, 202:87-97.
34. Herman J.P., Spencer R. Regulation of hippocampal glucocorticoid receptor gene transcription and protein expression in vivo. The Journal of Neuroscience 1998, 18:7462-7473.
35. Mansuy I.M., Shenolikar S. Protein serine/threonine phosphatases in neuronal plasticity and disorders of learning and memory. Trends in Neurosciences 2006, 29:679-686.
36. Dean D.A., Urban G., Aragon I.V., Swingle M., Miller B., Rusconi S., et al. Serine/threonine protein phosphatase 5 (PP5) participates in the regulation of glucocorticoid receptor nucleocytoplasmic shuttling. BMC Cell Biology 2001, 2:6.
37. Zuo Z., Urban G., Scammell J.G., Dean N.M., McLean T.K., Aragon I., et al. Ser/Thr protein phosphatase type 5 (PP5) is a negative regulator of glucocorticoid receptor-mediated growth arrest. Biochemistry 1999, 38:8849-8857.
38. Russell L.C., Whitt S.R., Chen M.S., Chinkers M. Identification of conserved residues required for the binding of a tetratricopeptide repeat domain to heat shock protein 90. Journal of Biological Chemistry 1999, 274:20060-20063.